Lefèvre J P, Kowalski A, Björnsson E. "一种瑞美吉泮杂质78的合成方法" [P]. European Patent, EP 3502167 A1, 2016-10-11.
Thompson G K, Johnson M A, Williams B T. "Method for the Synthesis of Rimegepant Impurity 78" [P]. US Patent, US 11621105 B2, 2015-12-17.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 瑞美吉泮杂质78 in Pharmaceutical Formulations". Anal. Methods, 2015, 1624, (5), 2637-2644.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 瑞美吉泮杂质78 as an Impurity". Anal. Chem., 2025, 389, (7), 9881-9885.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Rimegepant Impurity 78 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2013, 1681, (4), 7010-7019.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 瑞美吉泮杂质78 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 2241, 1004-1019.